Unravelling the behavioural and molecular hallmarks of Spinocerebellar Ataxia type 17 (SCA17). Studies on a transgenic rat model

Background: Measuring anxiety in a reliable manner is essential for behavioural phenotyping of rodent models such as the rat model for Spinocerebellar ataxia type 17 (SCA17) where anxiety is reported in patients. An automated tool for assessing anxiety within the home cage can minimize human intervention, stress of handling, transportation and novelty. New method: We applied the anxiety test “light spot” (LS) (white led directed at the food-hopper) to our transgenic SCA17 rat model in the PhenoTyper 4500® to extend the knowledge of this automated tool for behavioural phenotyping and to verify an anxietylike phenotype at three different disease stages for use in future therapeutic studies. Results: Locomotor activity was increased in SCA17 rats at 6 and 9 months during the first 15 minutes of the LS, potentially reflecting increased risk assessment. Both genotypes responded to the test with lower duration in the LS zone and higher time spent inside the shelter compared to baseline. Comparison with existing methods: We present the first data of a rat model subjected to the LS. The LS can be considered more biologically relevant than a traditional test as it measures anxiety in a familiar situation. Conclusions: The LS successfully evoked avoidance and shelter-seeking in rats. SCA17 rats showed a stronger approach-avoidance conflict reflected by increased activity in the area outside the LS. This home cage test, continuously monitoring preand posteffects, provides the opportunity for in-depth analysis, making it a potentially useful tool for detecting subtle or complex anxiety-related traits in rodents.

[1]  I. Loubinoux,et al.  Focal Malonate Injection Into the Internal Capsule of Rats as a Model of Lacunar Stroke , 2018, Front. Neurol..

[2]  K. Kondrakiewicz,et al.  Ecological validity of social interaction tests in rats and mice , 2018, Genes, brain, and behavior.

[3]  P. Dijkers,et al.  Inhibition of NF-κB in astrocytes is sufficient to delay neurodegeneration induced by proteotoxicity in neurons , 2018, Journal of Neuroinflammation.

[4]  H. Paulson,et al.  Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice , 2018, Annals of neurology.

[5]  H. Petry,et al.  AAV5-miHTT Gene Therapy Demonstrates Broad Distribution and Strong Human Mutant Huntingtin Lowering in a Huntington’s Disease Minipig Model , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  S. Peters The importance of rat social behavior for translational research : An ethological approach , 2018 .

[7]  Claudia Mazzà,et al.  A systematic review of the gait characteristics associated with Cerebellar Ataxia. , 2018, Gait & posture.

[8]  Zhen Li,et al.  Social interaction with a cagemate in pain increases allogrooming and induces pain hypersensitivity in the observer rats , 2018, Neuroscience Letters.

[9]  M. T. Lorbach,et al.  Automated Recognition of Rodent Social Behavior , 2017 .

[10]  Elisavet I. Kyriakou,et al.  The BACHD Rat Model of Huntington Disease Shows Specific Deficits in a Test Battery of Motor Function , 2017, Front. Behav. Neurosci..

[11]  Yan Wang,et al.  The Locus Coeruleus–Norepinephrine System Mediates Empathy for Pain through Selective Up-Regulation of P2X3 Receptor in Dorsal Root Ganglia in Rats , 2017, Front. Neural Circuits.

[12]  Elisavet I. Kyriakou,et al.  Home-cage anxiety levels in a transgenic rat model for Spinocerebellar ataxia type 17 measured by an approach-avoidance task: The light spot test , 2017, Journal of Neuroscience Methods.

[13]  Shihua Li,et al.  Genetically modified rodent models of SCA17 , 2017, Journal of neuroscience research.

[14]  H. van Attikum,et al.  Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice , 2017, Molecular therapy. Nucleic acids.

[15]  Elisavet I. Kyriakou,et al.  Learning to recognize rat social behavior: Novel dataset and cross-dataset application , 2017, Journal of Neuroscience Methods.

[16]  Rowland R. Sillito,et al.  Assessing mouse behaviour throughout the light/dark cycle using automated in-cage analysis tools , 2017, Journal of Neuroscience Methods.

[17]  P. Bauer,et al.  Capturing schizophrenia-like prodromal symptoms in a spinocerebellar ataxia-17 transgenic rat , 2017, Journal of psychopharmacology.

[18]  Elisavet I. Kyriakou,et al.  Anxiety and risk assessment-related traits in a rat model of Spinocerebellar ataxia type 17 , 2017, Behavioural Brain Research.

[19]  J. Homberg,et al.  Comeback of the Rat in Biomedical Research. , 2017, ACS chemical neuroscience.

[20]  N. Sousa,et al.  PhenoWorld: addressing animal welfare in a new paradigm to house and assess rat behaviour , 2017, Laboratory animals.

[21]  Kristin Branson,et al.  Machine vision methods for analyzing social interactions , 2017, Journal of Experimental Biology.

[22]  H. Würbel,et al.  The Researchers’ View of Scientific Rigor—Survey on the Conduct and Reporting of In Vivo Research , 2016, PloS one.

[23]  Jeremy D. Schmahmann,et al.  Cerebellar Contribution to Social Cognition , 2016, The Cerebellum.

[24]  B. Ellenbroek,et al.  Rodent models in neuroscience research: is it a rat race? , 2016, Disease Models & Mechanisms.

[25]  H. Nguyen,et al.  B46 The HD-like type 4/SCA17 disease protein TBP is cleaved by calpains in vitro and in vivo , 2016 .

[26]  Elisavet I. Kyriakou,et al.  Automated quantitative analysis to assess motor function in different rat models of impaired coordination and ataxia , 2016, Journal of Neuroscience Methods.

[27]  I. J. Pinter,et al.  Novel approach to automatically classify rat social behavior using a video tracking system , 2016, Journal of Neuroscience Methods.

[28]  Jennie R. Green,et al.  Loss of MeCP2 in the rat models regression, impaired sociability and transcriptional deficits of Rett syndrome , 2016, Human molecular genetics.

[29]  J. Silverman,et al.  Behavioral Phenotyping of Juvenile Long-Evans and Sprague-Dawley Rats: Implications for Preclinical Models of Autism Spectrum Disorders , 2016, PloS one.

[30]  T. Kimchi,et al.  From classic ethology to modern neuroethology: overcoming the three biases in social behavior research , 2016, Current Opinion in Neurobiology.

[31]  L. Guarente,et al.  Caloric restriction blocks neuropathology and motor deficits in Machado–Joseph disease mouse models through SIRT1 pathway , 2016, Nature Communications.

[32]  S. Leng,et al.  Rapamycin increases grip strength and attenuates age-related decline in maximal running distance in old low capacity runner rats , 2016, Aging.

[33]  S. Dunnett,et al.  Systematic and detailed analysis of behavioural tests in the rat middle cerebral artery occlusion model of stroke: Tests for long-term assessment , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[34]  O. Riess,et al.  The calpain-suppressing effects of olesoxime in Huntington's disease , 2016, Rare diseases.

[35]  Shihua Li,et al.  Molecular mechanisms underlying Spinocerebellar Ataxia 17 (SCA17) pathogenesis , 2016, Rare diseases.

[36]  Shenmin Zhang,et al.  Studying polyglutamine diseases in Drosophila , 2015, Experimental Neurology.

[37]  C. Calaminus,et al.  Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat. , 2015, Brain : a journal of neurology.

[38]  Emmeke Aarts,et al.  The light spot test: Measuring anxiety in mice in an automated home-cage environment , 2015, Behavioural Brain Research.

[39]  Ji-feng Guo,et al.  Large Polyglutamine Repeats Cause Muscle Degeneration in SCA17 Mice. , 2015, Cell reports.

[40]  Edith V. Sullivan,et al.  Cross-sectional versus longitudinal estimates of age-related changes in the adult brain: overlaps and discrepancies , 2015, Neurobiology of Aging.

[41]  Patrick L Wintrode,et al.  Enhanced Molecular Mobility of Ordinarily Structured Regions Drives Polyglutamine Disease* , 2015, The Journal of Biological Chemistry.

[42]  B. Spruijt,et al.  Ethological concepts enhance the translational value of animal models. , 2015, European journal of pharmacology.

[43]  A. Calas,et al.  Early ALS-type gait abnormalities in AMP-dependent protein kinase-deficient mice suggest a role for this metabolic sensor in early stages of the disease , 2015, Metabolic Brain Disease.

[44]  Jinn-Moon Yang,et al.  The potential of lactulose and melibiose, two novel trehalase-indigestible and autophagy-inducing disaccharides, for polyQ-mediated neurodegenerative disease treatment. , 2015, Neurotoxicology.

[45]  J. Barrett,et al.  The pain of pain: challenges of animal behavior models. , 2015, European journal of pharmacology.

[46]  W. Krzyzosiak,et al.  The Role of the Immune System in Triplet Repeat Expansion Diseases , 2015, Mediators of inflammation.

[47]  H. Orr,et al.  Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1 , 2015, Neuroscience.

[48]  Claire Richardson,et al.  The power of automated behavioural homecage technologies in characterizing disease progression in laboratory mice: A review , 2015 .

[49]  H. Hsieh-Li,et al.  Deactivation of TBP contributes to SCA17 pathogenesis. , 2014, Human molecular genetics.

[50]  D. Kaufer,et al.  Stress, social behavior, and resilience: Insights from rodents , 2014, Neurobiology of Stress.

[51]  T. Mikkelsen,et al.  SCA 17 phenotype with intermediate triplet repeat number , 2014, Journal of the Neurological Sciences.

[52]  G. Koutsis,et al.  From Mild Ataxia to Huntington Disease Phenocopy: The Multiple Faces of Spinocerebellar Ataxia 17 , 2014, Case reports in neurological medicine.

[53]  P. Perona,et al.  Toward a Science of Computational Ethology , 2014, Neuron.

[54]  A. Sowa,et al.  From Pathways to Targets: Understanding the Mechanisms behind Polyglutamine Disease , 2014, BioMed research international.

[55]  I. Golani,et al.  Display of individuality in avoidance behavior and risk assessment of inbred mice , 2014, Front. Behav. Neurosci..

[56]  B. Davidson,et al.  Nonallele specific silencing of ataxin-7 improves disease phenotypes in a mouse model of SCA7. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[57]  Berry M. Spruijt,et al.  Reproducibility and relevance of future behavioral sciences should benefit from a cross fertilization of past recommendations and today's technology: “Back to the future” , 2014, Journal of Neuroscience Methods.

[58]  O. Riess,et al.  Automated phenotyping and advanced data mining exemplified in rats transgenic for Huntington's disease , 2014, Journal of Neuroscience Methods.

[59]  S. Koekkoek,et al.  Cerebellar control of gait and interlimb coordination , 2014, Brain Structure and Function.

[60]  A. Ennaceur Tests of unconditioned anxiety — Pitfalls and disappointments , 2014, Physiology & Behavior.

[61]  L. Vanderschuren,et al.  Strain- and context-dependent effects of the anandamide hydrolysis inhibitor URB597 on social behavior in rats , 2014, European Neuropsychopharmacology.

[62]  Niklas Marklund,et al.  Structured evaluation of rodent behavioral tests used in drug discovery research , 2014, Front. Behav. Neurosci..

[63]  Yan Wang,et al.  Social interaction with a cagemate in pain facilitates subsequent spinal nociception via activation of the medial prefrontal cortex in rats , 2014, PAIN®.

[64]  Bror Alstermark,et al.  Skilled Reaching and Grasping in the Rat: Lacking Effect of Corticospinal Lesion , 2014, Front. Neurol..

[65]  Elad Schneidman,et al.  Correction: High-order social interactions in groups of mice , 2014, eLife.

[66]  W. Krzyzosiak,et al.  Oligonucleotide-based strategies to combat polyglutamine diseases , 2014, Nucleic acids research.

[67]  Christina A. Wilson,et al.  Social interaction and social withdrawal in rodents as readouts for investigating the negative symptoms of schizophrenia , 2014, European Neuropsychopharmacology.

[68]  H. Harn,et al.  Polyglutamine (PolyQ) Diseases: Genetics to Treatments , 2014, Cell transplantation.

[69]  C. Belzung Innovative Drugs to Treat Depression: Did Animal Models Fail to Be Predictive or Did Clinical Trials Fail to Detect Effects? , 2014, Neuropsychopharmacology.

[70]  L. Vanderschuren,et al.  Social play behavior, ultrasonic vocalizations and their modulation by morphine and amphetamine in Wistar and Sprague-Dawley rats , 2014, Psychopharmacology.

[71]  Annemieke Aartsma-Rus,et al.  Assessing functional performance in the mdx mouse model. , 2014, Journal of visualized experiments : JoVE.

[72]  Shihua Li,et al.  Age-Dependent Decrease in Chaperone Activity Impairs MANF Expression, Leading to Purkinje Cell Degeneration in Inducible SCA17 Mice , 2014, Neuron.

[73]  A. Lees,et al.  Late onset ataxia: MSA‐C or SCA 17? A gene penetrance dilemma , 2014, Movement disorders : official journal of the Movement Disorder Society.

[74]  P. Bickford,et al.  Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia , 2013, Neuropharmacology.

[75]  M. Merello,et al.  Autosomal dominant cerebellar ataxias: A systematic review of clinical features , 2013, Journal of the Neurological Sciences.

[76]  H. Paulson,et al.  Silencing Mutant ATXN3 Expression Resolves Molecular Phenotypes in SCA3 Transgenic Mice. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[77]  P. Rustin,et al.  Friedreich's Ataxia, Frataxin, PIP5K1B: Echo of a Distant Fracas , 2013, Oxidative medicine and cellular longevity.

[78]  Vittorio Murino,et al.  Automatic Visual Tracking and Social Behaviour Analysis with Multiple Mice , 2013, PloS one.

[79]  O. Riess,et al.  Automated home cage assessment shows behavioral changes in a transgenic mouse model of spinocerebellar ataxia type 17 , 2013, Behavioural Brain Research.

[80]  R. Schreiber,et al.  Assessment of Motor Function, Sensory Motor Gating and Recognition Memory in a Novel BACHD Transgenic Rat Model for Huntington Disease , 2013, PloS one.

[81]  P. Corr Approach and Avoidance Behaviour: Multiple Systems and their Interactions , 2013 .

[82]  I. Guzhova,et al.  Pharmacological protein targets in polyglutamine diseases: Mutant polypeptides and their interactors , 2013, FEBS letters.

[83]  O. Feinerman,et al.  Automated long-term tracking and social behavioural phenotyping of animal colonies within a semi-natural environment , 2013, Nature Communications.

[84]  Mariam Alaverdashvili,et al.  A behavioral method for identifying recovery and compensation: Hand use in a preclinical stroke model using the single pellet reaching task , 2013, Neuroscience & Biobehavioral Reviews.

[85]  C. Calaminus,et al.  A Novel Transgenic Rat Model for Spinocerebellar Ataxia Type 17 Recapitulates Neuropathological Changes and Supplies In Vivo Imaging Biomarkers , 2013, The Journal of Neuroscience.

[86]  A. Kubatiev,et al.  Increased Cell Fusion in Cerebral Cortex May Contribute to Poststroke Regeneration , 2013, Stroke research and treatment.

[87]  F. Chaouloff Social stress models in depression research: what do they tell us? , 2013, Cell and Tissue Research.

[88]  I. Tarkka,et al.  Gait Impairment in a Rat Model of Focal Cerebral Ischemia , 2013, Stroke research and treatment.

[89]  Kai Vogeley,et al.  Towards a neuroscience of social interaction , 2013, Front. Hum. Neurosci..

[90]  C. Richter,et al.  Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type 3 (SCA3). , 2013, Human molecular genetics.

[91]  F. Tortella,et al.  Longitudinal assessment of gait abnormalities following penetrating ballistic-like brain injury in rats , 2013, Journal of Neuroscience Methods.

[92]  Kristin Branson,et al.  JAABA: interactive machine learning for automatic annotation of animal behavior , 2013, Nature Methods.

[93]  Yoav Benjamini,et al.  Measuring behavior of animal models: faults and remedies , 2012, Nature Methods.

[94]  B. Spruijt,et al.  High‐throughput phenotyping of avoidance learning in mice discriminates different genotypes and identifies a novel gene , 2012, Genes, brain, and behavior.

[95]  Wojciech J. Szlachcic,et al.  Mouse Models of Polyglutamine Diseases: Review and Data Table. Part I , 2012, Molecular Neurobiology.

[96]  A. Bird,et al.  Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome. , 2012, Brain : a journal of neurology.

[97]  L. Friberg,et al.  Severe and rapidly progressing cognitive phenotype in a SCA17-family with only marginally expanded CAG/CAA repeats in the TATA-box binding protein gene: A case report , 2012, BMC Neurology.

[98]  L. Schöls,et al.  PET and MRI Reveal Early Evidence of Neurodegeneration in Spinocerebellar Ataxia Type 17 , 2012, The Journal of Nuclear Medicine.

[99]  Olaf Riess,et al.  Automated behavioral phenotyping reveals presymptomatic alterations in a SCA3 genetrap mouse model. , 2012, Journal of genetics and genomics = Yi chuan xue bao.

[100]  Martin L. Duennwald,et al.  Impaired Heat Shock Response in Cells Expressing Full-Length Polyglutamine-Expanded Huntingtin , 2012, PloS one.

[101]  A. Bonnet,et al.  Tremor-spectrum in spinocerebellar ataxia type 3 , 2012, Journal of Neurology.

[102]  M. H. Angelis,et al.  Pink1-deficiency in mice impairs gait, olfaction and serotonergic innervation of the olfactory bulb , 2012, Experimental Neurology.

[103]  A. Meisel,et al.  Gait analysis as a method for assessing neurological outcome in a mouse model of stroke , 2012, Journal of Neuroscience Methods.

[104]  A. Cressant,et al.  Computerized video analysis of social interactions in mice , 2012, Nature Methods.

[105]  Lori-Ann R. Sacrey,et al.  The use of rodent skilled reaching as a translational model for investigating brain damage and disease , 2012, Neuroscience & Biobehavioral Reviews.

[106]  Adam Claridge‐Chang,et al.  The surveillance state of behavioral automation , 2012, Current Opinion in Neurobiology.

[107]  M. Paulus,et al.  Executive function and PTSD: Disengaging from trauma , 2012, Neuropharmacology.

[108]  Y. Temel,et al.  Automated gait analysis in bilateral Parkinsonian rats and the role of l-DOPA therapy , 2012, Behavioural Brain Research.

[109]  Alexander Klein,et al.  Analysis of Skilled Forelimb Movement in Rats: The Single Pellet Reaching Test and Staircase Test , 2012, Current protocols in neuroscience.

[110]  T. Steimer,et al.  Animal models of anxiety disorders in rats and mice: some conceptual issues , 2011, Dialogues in clinical neuroscience.

[111]  T. Wannier,et al.  Behavioral Assessment of Manual Dexterity in Non-Human Primates , 2011, Journal of visualized experiments : JoVE.

[112]  C. Belzung,et al.  Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression , 2011, Biology of Mood & Anxiety Disorders.

[113]  M. Seshadri,et al.  Spinocerebellar ataxia type 17 in Indian patients: two rare cases of homozygous expansions , 2011, Clinical genetics.

[114]  L. Lu,et al.  A Drosophila model of the neurodegenerative disease SCA17 reveals a role of RBP-J/Su(H) in modulating the pathological outcome. , 2011, Human molecular genetics.

[115]  H. Hsieh-Li,et al.  Neuroprotective effects of granulocyte‐colony stimulating factor in a novel transgenic mouse model of SCA17 , 2011, Journal of neurochemistry.

[116]  Joseph J. Ling,et al.  Neuronal expression of TATA box-binding protein containing expanded polyglutamine in knock-in mice reduces chaperone protein response by impairing the function of nuclear factor-Y transcription factor. , 2011, Brain : a journal of neurology.

[117]  I. Liberzon,et al.  The Neurocircuitry of Fear, Stress, and Anxiety Disorders , 2011, Neuropsychopharmacology.

[118]  Jane S. Paulsen,et al.  Assessment of Depression, Anxiety and Apathy in Prodromal and Early Huntington Disease , 2011, PLoS currents.

[119]  Z. Wszolek,et al.  Autosomal dominant cerebellar ataxia type I: A review of the phenotypic and genotypic characteristics , 2011, Orphanet journal of rare diseases.

[120]  R. Schiffmann,et al.  Altered Dopamine and Serotonin Metabolism in Motorically Asymptomatic R6/2 Mice , 2011, PloS one.

[121]  L. Peltonen,et al.  Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland , 2011, European Journal of Human Genetics.

[122]  J. Roder,et al.  Assessment of Social Interaction Behaviors , 2011, Journal of visualized experiments : JoVE.

[123]  J. Guralnik,et al.  Translating Research to Promote Healthy Aging: The Complementary Role of Longitudinal Studies and Clinical Trials , 2010, Journal of the American Geriatrics Society.

[124]  L. Vanderschuren,et al.  The pleasures of play: pharmacological insights into social reward mechanisms. , 2010, Trends in pharmacological sciences.

[125]  P. Maciel,et al.  Motor uncoordination and neuropathology in a transgenic mouse model of Machado–Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products , 2010, Neurobiology of Disease.

[126]  L. Cipolotti,et al.  A Preliminary Characterisation of Cognition and Social Cognition in Spinocerebellar Ataxia Types 2, 1, and 7 , 2010, Behavioural neurology.

[127]  Koen Van Laere,et al.  Automated quantitative gait analysis in animal models of movement disorders , 2010, BMC Neuroscience.

[128]  S. Savitz,et al.  Functional assessments in the rodent stroke model , 2010, Experimental & Translational Stroke Medicine.

[129]  C. Lichy,et al.  Spinocerebellar ataxia type 17 associated with an expansion of 42 glutamine residues in TATA-box binding protein gene , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[130]  N. Müller,et al.  Neuroinflammation, Microglia and Implications for Anti-Inflammatory Treatment in Alzheimer's Disease , 2010, International journal of Alzheimer's disease.

[131]  G. Garden,et al.  A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia , 2010, Journal of visualized experiments : JoVE.

[132]  Shihua Li,et al.  Polyglutamine toxicity in non-neuronal cells , 2010, Cell Research.

[133]  S. Cardoso,et al.  Dysfunctional mitochondria uphold calpain activation: Contribution to Parkinson's disease pathology , 2010, Neurobiology of Disease.

[134]  Chuan-en Wang,et al.  Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms , 2009, Proceedings of the National Academy of Sciences.

[135]  Shihua Li,et al.  Transcriptional dysregulation of TrkA associates with neurodegeneration in spinocerebellar ataxia type 17. , 2009, Human molecular genetics.

[136]  N. Nukina,et al.  The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies , 2009, Journal of neurochemistry.

[137]  Makoto Hashimoto,et al.  Possible roles of microglial cells for neurotoxicity in clinical neurodegenerative diseases and experimental animal models. , 2009, Inflammation & allergy drug targets.

[138]  Shihua Li,et al.  Activation of Gene Transcription by Heat Shock Protein 27 May Contribute to Its Neuronal Protection* , 2009, The Journal of Biological Chemistry.

[139]  Antonio Krüger,et al.  Behavioral phenotyping of a murine model of Alzheimer’s disease in a seminaturalistic environment using RFID tracking , 2009, Behavior research methods.

[140]  A. H. Veenema,et al.  Maternal separation enhances offensive play-fighting, basal corticosterone and hypothalamic vasopressin mRNA expression in juvenile male rats , 2009, Psychoneuroendocrinology.

[141]  J. Marsh,et al.  Animal Models of Polyglutamine Diseases and Therapeutic Approaches* , 2009, Journal of Biological Chemistry.

[142]  G. Walenkamp,et al.  The CatWalk method: Assessment of mechanical allodynia in experimental chronic pain , 2009, Behavioural Brain Research.

[143]  T. Suuronen,et al.  Inflammation in Alzheimer's disease: Amyloid-β oligomers trigger innate immunity defence via pattern recognition receptors , 2009, Progress in Neurobiology.

[144]  R. Shin,et al.  Severe neurological phenotypes of Q129 DRPLA transgenic mice serendipitously created by en masse expansion of CAG repeats in Q76 DRPLA mice , 2008, Human molecular genetics.

[145]  S. Ferdinandusse,et al.  Ataxia with loss of Purkinje cells in a mouse model for Refsum disease , 2008, Proceedings of the National Academy of Sciences.

[146]  M. Chesselet,et al.  Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice , 2008, Neuroscience.

[147]  J. Hermsdörfer,et al.  Impairments of prehension kinematics and grasping forces in patients with cerebellar degeneration and the relationship to cerebellar atrophy , 2008, Clinical Neurophysiology.

[148]  J. Castro-Lopes,et al.  Assessment of movement-evoked pain in osteoarthritis by the knee-bend and CatWalk tests: a clinically relevant study. , 2008, The journal of pain : official journal of the American Pain Society.

[149]  F.P.T. Hamers,et al.  Using the CatWalk method to assess weight-bearing and pain behaviour in walking rats with ankle joint monoarthritis induced by carrageenan: Effects of morphine and rofecoxib , 2008, Journal of Neuroscience Methods.

[150]  R. Paylor,et al.  Pitfalls in the interpretation of genetic and pharmacological effects on anxiety-like behaviour in rodents , 2008, Behavioural pharmacology.

[151]  I. Whishaw,et al.  The problem of relating plasticity and skilled reaching after motor cortex stroke in the rat , 2008, Behavioural Brain Research.

[152]  G. Brook,et al.  CatWalk gait analysis in assessment of functional recovery after sciatic nerve injury , 2008, Journal of Neuroscience Methods.

[153]  M. Hayden,et al.  A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease , 2008, The Journal of experimental medicine.

[154]  Charlotte C. Burn,et al.  What is it like to be a rat? Rat sensory perception and its implications for experimental design and rat welfare , 2008 .

[155]  T. Yeh,et al.  Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation , 2008, Neurobiology of Disease.

[156]  N. Banik,et al.  Calpain as a potential therapeutic target in Parkinson's disease. , 2008, CNS & neurological disorders drug targets.

[157]  W. Streit,et al.  Microglial degeneration in the aging brain--bad news for neurons? , 2008, Frontiers in bioscience : a journal and virtual library.

[158]  L. Spear,et al.  Social interactions in adolescent and adult Sprague–Dawley rats: Impact of social deprivation and test context familiarity , 2008, Behavioural Brain Research.

[159]  Chuan-en Wang,et al.  Polyglutamine Expansion Reduces the Association of TATA-binding Protein with DNA and Induces DNA Binding-independent Neurotoxicity* , 2008, Journal of Biological Chemistry.

[160]  J. Opitz,et al.  X‐linked congenital ataxia: A new locus maps to Xq25‐q27.1 , 2008, American journal of medical genetics. Part A.

[161]  M. DeLegge,et al.  Neurodegeneration and Inflammation. , 2008, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[162]  G. Brook,et al.  Strain and locomotor speed affect over-ground locomotion in intact rats , 2007, Physiology & Behavior.

[163]  S. Warren,et al.  Polyglutamine domain modulates the TBP-TFIIB interaction: implications for its normal function and neurodegeneration , 2007, Nature Neuroscience.

[164]  M. Diamond,et al.  Polyglutamine diseases: emerging concepts in pathogenesis and therapy. , 2007, Human molecular genetics.

[165]  C. Lovati,et al.  Spinocerebellar ataxia type 17 (SCA17): Oculomotor phenotype and clinical characterization of 15 Italian patients , 2007, Journal of Neurology.

[166]  Chiara Gagliardi,et al.  Disorders of cognitive and affective development in cerebellar malformations. , 2007, Brain : a journal of neurology.

[167]  A. Etkin,et al.  Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. , 2007, The American journal of psychiatry.

[168]  Y. Temel,et al.  High frequency stimulation of the subthalamic nucleus improves speed of locomotion but impairs forelimb movement in Parkinsonian rats , 2007, Neuroscience.

[169]  M. Vamos,et al.  The impact of Huntington's disease on family life. , 2007, Psychosomatics.

[170]  M. Marcus,et al.  The CatWalk gait analysis in assessment of both dynamic and static gait changes after adult rat sciatic nerve resection , 2007, Journal of Neuroscience Methods.

[171]  Howard Schulman,et al.  Global changes to the ubiquitin system in Huntington's disease , 2007, Nature.

[172]  L. Rüttiger,et al.  Nuclear Localization of Ataxin-3 Is Required for the Manifestation of Symptoms in SCA3: In Vivo Evidence , 2007, The Journal of Neuroscience.

[173]  F. Hartl,et al.  Calpain Inhibition Is Sufficient to Suppress Aggregation of Polyglutamine-expanded Ataxin-3* , 2007, Journal of Biological Chemistry.

[174]  H. Zoghbi,et al.  Trinucleotide repeat disorders. , 2007, Annual review of neuroscience.

[175]  G. Walenkamp,et al.  The CatWalk method: A detailed analysis of behavioral changes after acute inflammatory pain in the rat , 2007, Journal of Neuroscience Methods.

[176]  K. Gwinn‐Hardy,et al.  The SCA17 phenotype can include features of MSA-C, PSP and cognitive impairment. , 2007, Parkinsonism & related disorders.

[177]  Garet P. Lahvis,et al.  Affiliative Behavior, Ultrasonic Communication and Social Reward Are Influenced by Genetic Variation in Adolescent Mice , 2007, PloS one.

[178]  Rodney C. Samaco,et al.  Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes , 2007, Nature Genetics.

[179]  P. Thier,et al.  Specific influences of cerebellar dysfunctions on gait. , 2007, Brain : a journal of neurology.

[180]  J. Schwankhaus,et al.  Case of spinocerebellar ataxia type 17 (SCA17) associated with only 41 repeats of the TATA‐binding protein (TBP) gene , 2007, Movement disorders : official journal of the Movement Disorder Society.

[181]  J. Henderson,et al.  Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson's disease , 2007, Journal of Neuroscience Methods.

[182]  C. Lowry,et al.  Exposure to high- and low-light conditions in an open-field test of anxiety increases c-Fos expression in specific subdivisions of the rat basolateral amygdaloid complex , 2006, Brain Research Bulletin.

[183]  A. Parent,et al.  The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea. , 2006, Brain : a journal of neurology.

[184]  Shelley E. Taylor Tend and Befriend , 2006 .

[185]  Ronald Wetzel,et al.  Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease. , 2006, Human molecular genetics.

[186]  A. Barrientos,et al.  Cytotoxicity of a mutant huntingtin fragment in yeast involves early alterations in mitochondrial OXPHOS complexes II and III. , 2006, Human molecular genetics.

[187]  U Walter,et al.  Morphological basis for the spectrum of clinical deficits in spinocerebellar ataxia 17 (SCA17). , 2006, Brain : a journal of neurology.

[188]  Harry T Orr,et al.  Polyglutamine neurodegenerative diseases and regulation of transcription: assembling the puzzle. , 2006, Genes & development.

[189]  L. de Visser,et al.  Novel approach to the behavioural characterization of inbred mice: automated home cage observations , 2006, Genes, brain, and behavior.

[190]  M. Tuszynski,et al.  A form of motor cortical plasticity that correlates with recovery of function after brain injury. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[191]  Berry M Spruijt,et al.  Advanced behavioural screening: automated home cage ethology. , 2006, Drug discovery today. Technologies.

[192]  F.P.T. Hamers,et al.  CatWalk-assisted gait analysis in the assessment of spinal cord injury. , 2006, Journal of neurotrauma.

[193]  R. Snell,et al.  TATA-binding protein in neurodegenerative disease , 2005, Neuroscience.

[194]  P. Chinnery,et al.  Minimum prevalence of spinocerebellar ataxia 17 in the north east of England , 2005, Journal of the Neurological Sciences.

[195]  S. McMahon,et al.  Assessing behavioural function following a pyramidotomy lesion of the corticospinal tract in adult mice , 2005, Experimental Neurology.

[196]  H. Urbach,et al.  Putamen dopamine transporter and glucose metabolism are reduced in SCA17 , 2005, Annals of neurology.

[197]  Bastiaan R Bloem,et al.  Trunk sway in patients with spinocerebellar ataxia , 2005, Movement disorders : official journal of the Movement Disorder Society.

[198]  E. Schwinger,et al.  Spinocerebellar ataxia type 17: Report of a family with reduced penetrance of an unstable Gln49 TBP allele, haplotype analysis supporting a founder effect for unstable alleles and comparative analysis of SCA17 genotypes , 2005, BMC Medical Genetics.

[199]  P. Boguszewski,et al.  Expression of c-Fos in response to stressogenic stimuli in the amygdala of old vs. young rats--a preliminary study. , 2005, Acta neurobiologiae experimentalis.

[200]  D. Nowak,et al.  Preserved and impaired aspects of predictive grip force control in cerebellar patients , 2005, Clinical Neurophysiology.

[201]  M. Savontaus,et al.  The occurrence of dominant spinocerebellar ataxias among 251 Finnish ataxia patients and the role of predisposing large normal alleles in a genetically isolated population , 2005, Acta neurologica Scandinavica.

[202]  A. Zeman,et al.  Neurological syndromes which can be mistaken for psychiatric conditions , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[203]  A. Kalueff,et al.  Mouse grooming microstructure is a reliable anxiety marker bidirectionally sensitive to GABAergic drugs. , 2005, European journal of pharmacology.

[204]  Niels Kuster,et al.  Whole-body exposure to 2.45GHz electromagnetic fields does not alter anxiety responses in rats: a plus-maze study including test validation , 2005, Behavioural Brain Research.

[205]  Mark R. Segal,et al.  Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death , 2004, Nature.

[206]  Charles Duyckaerts,et al.  Behavioral disorder, dementia, ataxia, and rigidity in a large family with TATA box-binding protein mutation. , 2004, Archives of neurology.

[207]  M. Schwab,et al.  Behavioral testing strategies in a localized animal model of multiple sclerosis , 2004, Journal of Neuroimmunology.

[208]  Michael S Fanselow,et al.  Light stimulus change evokes an activity response in the rat , 2004, Learning & behavior.

[209]  Peter Breuer,et al.  Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation. , 2004, Molecular cell.

[210]  S. Sorbi,et al.  Spinocerebellar ataxia type 17 repeat in patients with Huntington's disease‐like and ataxia , 2004, Annals of neurology.

[211]  S. Hesse,et al.  Basal ganglia involvement of a patient with SCA 17 , 2004, Journal of Neurology.

[212]  M. Hayden,et al.  Inhibition of Calpain Cleavage of Huntingtin Reduces Toxicity , 2004, Journal of Biological Chemistry.

[213]  Thorsten Schmidt,et al.  Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis , 2004, The Lancet Neurology.

[214]  E. Nestler,et al.  Neurobehavioral assessment in the information age , 2004, Nature Neuroscience.

[215]  Alison Abbott,et al.  Laboratory animals: The Renaissance rat , 2004, Nature.

[216]  M. Mattson,et al.  Paroxetine retards disease onset and progression in Huntingtin mutant mice , 2004, Annals of neurology.

[217]  A. Ristić,et al.  Spinocerebellar ataxia type 17 in the Yugoslav population , 2004, Acta neurologica Scandinavica.

[218]  Osamu Onodera,et al.  SCA17 homozygote showing Huntington's disease‐like phenotype , 2004, Annals of neurology.

[219]  M. Oda,et al.  Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17. , 2004, Archives of neurology.

[220]  Christine Klein,et al.  Focal dystonia as a presenting sign of spinocerebellar ataxia 17 , 2004, Movement disorders : official journal of the Movement Disorder Society.

[221]  G. Coppola,et al.  Intergenerational instability and marked anticipation in SCA-17 , 2003, Neurology.

[222]  G. De Michele,et al.  Dementia, ataxia, extrapyramidal features, and epilepsy: phenotype spectrum in two Italian families with spinocerebellar ataxia type 17 , 2003, Neurological Sciences.

[223]  Olaf Riess,et al.  Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17) , 2003, Annals of neurology.

[224]  M. Sirard,et al.  Making recombinant proteins in animals--different systems, different applications. , 2003, Trends in biotechnology.

[225]  A. Morton,et al.  Microglia density decreases with age in a mouse model of Huntington's disease , 2003, Glia.

[226]  E. Schwinger,et al.  SCA17 caused by homozygous repeat expansion in TBP due to partial isodisomy 6 , 2003, European Journal of Human Genetics.

[227]  M. Hayden,et al.  Huntingtin and Huntingtin-Associated Protein 1 Influence Neuronal Calcium Signaling Mediated by Inositol-(1,4,5) Triphosphate Receptor Type 1 , 2003, Neuron.

[228]  A. Durr,et al.  Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes. , 2003, Brain : a journal of neurology.

[229]  M. Owen,et al.  Molecular investigation of TBP allele length: a SCA17 cellular model and population study , 2003, Neurobiology of Disease.

[230]  R. Landgraf Animal models of anxiety. , 2003, Stress.

[231]  A. Konnerth,et al.  Calbindin in Cerebellar Purkinje Cells Is a Critical Determinant of the Precision of Motor Coordination , 2003, The Journal of Neuroscience.

[232]  Thomas Walther,et al.  Transgenic rat model of Huntington's disease. , 2003, Human molecular genetics.

[233]  S. File,et al.  A review of 25 years of the social interaction test. , 2003, European journal of pharmacology.

[234]  C. Belzung,et al.  The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. , 2003, European journal of pharmacology.

[235]  M. Hascöet,et al.  The mouse light/dark box test. , 2003, European journal of pharmacology.

[236]  T. Sharp,et al.  Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs , 2003, Biological Psychiatry.

[237]  E. Schwinger,et al.  Phenotypical variability of expanded alleles in the TATA-binding protein gene , 2003, Journal of Neurology.

[238]  Ian Q Whishaw,et al.  A Novel Skilled-Reaching Impairment in Paw Supination on the “Good” Side of the Hemi-Parkinson Rat Improved with Rehabilitation , 2003, The Journal of Neuroscience.

[239]  Bin Liu,et al.  Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention , 2003, Journal of Pharmacology and Experimental Therapeutics.

[240]  T. Steimer,et al.  The biology of fear- and anxiety-related behaviors , 2002, Dialogues in clinical neuroscience.

[241]  G. Deuschl,et al.  Typical features of cerebellar ataxic gait , 2002, Journal of neurology, neurosurgery, and psychiatry.

[242]  M. Difiglia Huntingtin fragments that aggregate go their separate ways. , 2002, Molecular cell.

[243]  Ian Q. Whishaw,et al.  Animal models of neurological deficits: how relevant is the rat? , 2002, Nature Reviews Neuroscience.

[244]  L. Ellerby,et al.  Calpain Activation in Huntington's Disease , 2002, The Journal of Neuroscience.

[245]  M. Pook,et al.  YAC transgenic mice carrying pathological alleles of the MJD1 locus exhibit a mild and slowly progressive cerebellar deficit. , 2002, Human molecular genetics.

[246]  C. Broeckhoven,et al.  CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia. , 2001, Brain : a journal of neurology.

[247]  T. Klockgether,et al.  Inflammatory Genes Are Upregulated in Expanded Ataxin-3-Expressing Cell Lines and Spinocerebellar Ataxia Type 3 Brains , 2001, The Journal of Neuroscience.

[248]  I. Kanazawa,et al.  SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. , 2001, Human molecular genetics.

[249]  P. M. Wall,et al.  Methodological and conceptual issues in the use of the elevated plus-maze as a psychological measurement instrument of animal anxiety-like behavior , 2001, Neuroscience & Biobehavioral Reviews.

[250]  H. Orr,et al.  Beyond the Qs in the polyglutamine diseases. , 2001, Genes & development.

[251]  P. Vieregge,et al.  Different types of repeat expansion in the TATA-binding protein gene are associated with a new form of inherited ataxia , 2001, European Journal of Human Genetics.

[252]  S. Tsuji,et al.  Involvement of the cerebral cortex and autonomic ganglia in Machado-Joseph disease , 2001, Acta Neuropathologica.

[253]  M. Hascöet,et al.  The mouse ligth-dark paradigm: A review , 2001, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[254]  R. Albin,et al.  Neurological abnormalities in a knock-in mouse model of Huntington's disease. , 2001, Human molecular genetics.

[255]  C. Ross,et al.  Widespread occurrence of intranuclear atrophin‐1 accumulation in the central nervous system neurons of patients with dentatorubral‐pallidoluysian atrophy , 2001, Annals of neurology.

[256]  P. Lang,et al.  Fear and anxiety: animal models and human cognitive psychophysiology. , 2000, Journal of affective disorders.

[257]  S. Tsuji,et al.  Pathology of CAG repeat diseases , 2000, Neuropathology : official journal of the Japanese Society of Neuropathology.

[258]  Volker Dietz,et al.  Efficient testing of motor function in spinal cord injured rats , 2000, Brain Research.

[259]  S. Pulst,et al.  Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human , 2000, Nature Genetics.

[260]  R. Christopher,et al.  Trinucleotide repeats and neuropsychiatric disorders , 2000, Indian Journal of Clinical Biochemistry.

[261]  M. Zvolensky,et al.  Prediction and control: operational definitions for the experimental analysis of anxiety. , 2000, Behaviour research and therapy.

[262]  E. Bertini,et al.  X-linked congenital ataxia: a clinical and genetic study. , 2000, American journal of medical genetics.

[263]  D. Riva,et al.  The cerebellum contributes to higher functions during development: evidence from a series of children surgically treated for posterior fossa tumours. , 2000, Brain : a journal of neurology.

[264]  H. Zoghbi,et al.  Fourteen and counting: unraveling trinucleotide repeat diseases. , 2000, Human molecular genetics.

[265]  A. Holmes,et al.  Corticosterone response to the plus-maze High correlation with risk assessment in rats and mice , 1999, Physiology & Behavior.

[266]  Harry T Orr,et al.  Mutation of the E6-AP Ubiquitin Ligase Reduces Nuclear Inclusion Frequency While Accelerating Polyglutamine-Induced Pathology in SCA1 Mice , 1999, Neuron.

[267]  M. McInnis,et al.  Trinucleotide repeat expansion and neuropsychiatric disease. , 1999, Archives of general psychiatry.

[268]  S Kobayashi,et al.  A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease? , 1999, Human molecular genetics.

[269]  H. Zoghbi,et al.  Polyglutamine diseases: protein cleavage and aggregation , 1999, Current Opinion in Neurobiology.

[270]  I. Kanazawa,et al.  Abundant expression and cytoplasmic aggregations of [alpha]1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6. , 1999, Human molecular genetics.

[271]  E. Tolosa,et al.  Comparative analysis of gait in Parkinson's disease, cerebellar ataxia and subcortical arteriosclerotic encephalopathy. , 1999, Brain : a journal of neurology.

[272]  D. Rubinsztein,et al.  Intracellular inclusions, pathological markers in diseases caused by expanded polyglutamine tracts? , 1999, Journal of medical genetics.

[273]  S. W. Davies,et al.  Brain Neurotransmitter Deficits in Mice Transgenic for the Huntington’s Disease Mutation , 1999, Journal of neurochemistry.

[274]  B. Moghaddam,et al.  Dopaminergic Innervation of the Amygdala Is Highly Responsive to Stress , 1999, Journal of neurochemistry.

[275]  S. Morato,et al.  Ethopharmacological Analysis of 5-HT Ligands on the Rat Elevated Plus-Maze , 1999, Pharmacology Biochemistry and Behavior.

[276]  Michael Davis,et al.  Are different parts of the extended amygdala involved in fear versus anxiety? , 1998, Biological Psychiatry.

[277]  C. Dourish,et al.  Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety , 1998, Neuroscience & Biobehavioral Reviews.

[278]  Harry T Orr,et al.  Ataxin-1 Nuclear Localization and Aggregation Role in Polyglutamine-Induced Disease in SCA1 Transgenic Mice , 1998, Cell.

[279]  Steven Finkbeiner,et al.  Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions , 1998, Cell.

[280]  H. Lipe,et al.  Familial aggregation of schizophrenia-like symptoms in Huntington's disease. , 1998, American journal of medical genetics.

[281]  M. Hascöet,et al.  A New Approach to the Light/Dark Test Procedure in Mice , 1998, Pharmacology Biochemistry and Behavior.

[282]  Dale E. Bredesen,et al.  Caspase Cleavage of Gene Products Associated with Triplet Expansion Disorders Generates Truncated Fragments Containing the Polyglutamine Tract* , 1998, The Journal of Biological Chemistry.

[283]  L. Vanderschuren,et al.  The neurobiology of social play behavior in rats , 1997, Neuroscience & Biobehavioral Reviews.

[284]  R. Rodgers Animal models of 'anxiety': where next? , 1997, Behavioural pharmacology.

[285]  M. Brandão,et al.  Ethopharmacological analysis of behaviour of rats using variations of the elevated plus-maze , 1997, Behavioural pharmacology.

[286]  C. Belzung,et al.  Further pharmacological validation of the BALB/c neophobia in the free exploratory paradigm as an animal model of trait anxiety , 1997, Behavioural pharmacology.

[287]  Richard Paylor,et al.  Social Interaction and Sensorimotor Gating Abnormalities in Mice Lacking Dvl1 , 1997, Cell.

[288]  G. Perrault,et al.  Risk Assessment Behaviour: Evaluation of Utility in the Study of 5-HT-Related Drugs in the Rat Elevated Plus-Maze Test , 1997, Pharmacology Biochemistry and Behavior.

[289]  S. Watson Neuroendocrine and Behavioral Responses and Brain Pattern of c‐fos Induction Associated with Audiogenic Stress , 1997, Journal of neuroendocrinology.

[290]  M. Hayden,et al.  Of molecular interactions, mice and mechanisms: new insights into Huntington's disease. , 1997, Current opinion in neurology.

[291]  A. Holmes,et al.  Animal models of anxiety: an ethological perspective. , 1997, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[292]  R. Handa,et al.  Age-related changes in c-fos mRNA induction after open-field exposure in the rat brain , 1997, Neurobiology of Aging.

[293]  J. Higgins,et al.  Brain MRI, lumbar CSF monoamine concentrations, and clinical descriptors of patients with spinocerebellar ataxia mutations. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[294]  A. Diamond,et al.  Evidence for the importance of dopamine for prefrontal cortex functions early in life. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[295]  J. Hughes,et al.  The anxiolytics CI-988 and chlordiazepoxide fail to reduce immediate early gene mRNA stimulation following exposure to the rat elevated X-maze. , 1996, European journal of pharmacology.

[296]  M. Hahn,et al.  Issues in the genetics of social behavior: Revisited , 1996, Behavior genetics.

[297]  F. Cirulli,et al.  Affiliation in periadolescent rats: Behavioral and corticosterone response to social reunion with familiar or unfamiliar partners , 1996, Pharmacology Biochemistry and Behavior.

[298]  P. Patel,et al.  Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion , 1996, Science.

[299]  I. Pollack,et al.  Mutism and pseudobulbar symptoms after resection of posterior fossa tumors in children: incidence and pathophysiology. , 1995, Neurosurgery.

[300]  M. MacDonald,et al.  Huntington's disease CAG trinucleotide repeats in pathologically confirmed post-mortem brains , 1994, Neurobiology of Disease.

[301]  R. Tjian,et al.  Multiple regions of TBP participate in the response to transcriptional activators in vivo. , 1994, Genes & development.

[302]  J. Beckmann,et al.  The gene for the TATA binding protein (TBP) that contains a highly polymorphic protein coding CAG repeat maps to 6q27. , 1994, Genomics.

[303]  J. Costentin,et al.  Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions , 1994, Behavioural Brain Research.

[304]  R. Rodgers,et al.  Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol , 1994, Psychopharmacology.

[305]  G. Griebel,et al.  The free‐exploratory paradigm: an effective method for measuring neophobic behaviour in mice and testing potential neophobia‐reducing drugs , 1993, Behavioural pharmacology.

[306]  Y. Agid,et al.  Phenotypic variability in autosomal dominant cerebellar ataxia type I is unrelated to genetic heterogeneity. , 1993, Brain : a journal of neurology.

[307]  B. Gostout,et al.  "Cryptic" repeating triplets of purines and pyrimidines (cRRY(i)) are frequent and polymorphic: analysis of coding cRRY(i) in the proopiomelanocortin (POMC) and TATA-binding protein (TBP) genes. , 1993, American journal of human genetics.

[308]  L. V. Zutphen,et al.  Description and validation of a preference test system to evaluate housing conditions for laboratory mice , 1992 .

[309]  P. Harper The epidemiology of Huntington's disease , 1992, Human Genetics.

[310]  J. Sutcliffe,et al.  Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox , 1991, Cell.

[311]  P. Brain,et al.  Ethopharmacological studies on the effects of antihormones on rodent agonistic behavior with especial emphasis on progesterone , 1991, Neuroscience & Biobehavioral Reviews.

[312]  Miloš Kršiak,et al.  Ethopharmacology: A historical perspective , 1991, Neuroscience & Biobehavioral Reviews.

[313]  D. S. Rath,et al.  Trinucleotide repeat polymorphism at the human transcription factor IID gene. , 1991, Nucleic acids research.

[314]  K. Fischbeck,et al.  Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy , 1991, Nature.

[315]  Masami Horikoshi,et al.  Highly conserved core domain and unique N terminus with presumptive regulatory motifs in a human TATA factor (TFIID) , 1990, Nature.

[316]  P. Lieberman,et al.  Cloning of a transcriptionally active human TATA binding factor. , 1990, Science.

[317]  R. Tjian,et al.  Functional domains and upstream activation properties of cloned human TATA binding protein. , 1990, Science.

[318]  C. Carter,et al.  Effects of hormonal, sexual, and social history on mating and pair bonding in prairie voles , 1988, Physiology & Behavior.

[319]  S. Kish,et al.  Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum , 1987, Annals of neurology.

[320]  C. Finch,et al.  Dopamine and Serotonin Systems in Human and Rodent Brain: Effects of Age and Neurodegenerative Disease , 1987, Journal of the American Geriatrics Society.

[321]  Jaak Panksepp,et al.  The psychobiology of play: Theoretical and methodological perspectives , 1984, Neuroscience & Biobehavioral Reviews.

[322]  R. Niesink,et al.  Short-term isolation increases social interactions of male rats: A parametric analysis , 1982, Physiology & Behavior.

[323]  A. Harding The clinical features and classification of the late onset autosomal dominant cerebellar ataxias. A study of 11 families, including descendants of the 'the Drew family of Walworth'. , 1982, Brain : a journal of neurology.

[324]  J. Panksepp The ontogeny of play in rats. , 1981, Developmental psychobiology.

[325]  J. Panksepp,et al.  Social deprivation and play in rats. , 1980, Behavioral and neural biology.

[326]  S. File The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs , 1980, Journal of Neuroscience Methods.

[327]  A. Borbély,et al.  Daily pattern of sleep, motor activity and feeding in the rat: Effects of regular and gradually extended photoperiods , 1978, Journal of comparative physiology.

[328]  S. File,et al.  CAN SOCIAL INTERACTION BE USED TO MEASURE ANXIETY? , 1978, British journal of pharmacology.

[329]  Y. Teichman Predisposition for anxiety and affiliation. , 1974, Journal of personality and social psychology.

[330]  K. Jellinger,et al.  Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.

[331]  M. Manosevitz,et al.  Birth order, anxiety, and affiliation during a crisis. , 1968, Journal of personality and social psychology.

[332]  S. Glickman,et al.  A biological theory of reinforcement. , 1967, Psychological review.

[333]  D. Schonfield Memory Changes with Age , 1965, Nature.

[334]  A. Torres Anxiety versus escape conditioning and tranquilizing action. , 1961, Journal of comparative and physiological psychology.

[335]  P. Young The role of affective processes in learning and motivation. , 1959, Psychological review.

[336]  J. S. Brown,et al.  Gradients of approach and avoidance responses and their relation to level of motivation. , 1948, Journal of comparative and physiological psychology.

[337]  Marco Santochi,et al.  Grasping , 2019, CIRP Encyclopedia of Production Engineering.

[338]  M. Papp,et al.  Stress-induced anhedonia is associated with the activation of the inflammatory system in the rat brain: Restorative effect of pharmacological intervention. , 2016, Pharmacological research.

[339]  S. Pellis,et al.  Play, variation in play and the development of socially competent rats , 2016 .

[340]  I. Golani,et al.  Home Cage-Based Long-Term Monitoring of Fear in Mice: Novel Approach to Determine Individual Differences in Risk Assessment and Avoidance , 2014 .

[341]  B. Ruggeri,et al.  Animal models of human disease: challenges in enabling translation. , 2014, Biochemical pharmacology.

[342]  F. Guimarães,et al.  Animal models of anxiety disorders and stress. , 2013, Revista brasileira de psiquiatria.

[343]  Jenni M. Karl,et al.  Rodent Skilled Reaching for Modeling Pathological Conditions of the Human Motor System , 2011 .

[344]  M. Wood,et al.  Therapeutic gene silencing strategies for polyglutamine disorders. , 2010, Trends in genetics : TIG.

[345]  Olaf Riess,et al.  Neurobehavioral tests in rat models of degenerative brain diseases. , 2010, Methods in molecular biology.

[346]  Jacqueline N. Crawley,et al.  Anxiety-Related Behaviors in Mice , 2009 .

[347]  P. Solli,et al.  Longitudinal studies , 2009 .

[348]  K. Bürk,et al.  Spinocerebellar ataxia type 17 is caused by mutations in the TATA-box binding protein , 2008, The Cerebellum.

[349]  F. J. van der Staay,et al.  Pathological anxiety in animals. , 2008, Veterinary journal.

[350]  A. Brice,et al.  Spinocerebellar ataxia 17 (SCA17) and Huntington’s disease-like 4 (HDL4) , 2008, The Cerebellum.

[351]  A. Sterr,et al.  Neurobiology of learning and memory , 2008 .

[352]  B. Olatunji,et al.  A functional analysis of danger and safety signals in anxiety disorders. , 2007, Clinical psychology review.

[353]  A. Brice,et al.  Spinocerebellar Ataxia 17 and Huntington's Disease-like 4 , 2006 .

[354]  N. Garrett,et al.  Striatal dopamine and homovanillic acid in Huntington's Disease , 2005, Journal of Neural Transmission.

[355]  S. File,et al.  Raised corticosterone in the rat after exposure to the elevated plus-maze , 2005, Psychopharmacology.

[356]  John F. Cryan,et al.  Model organisms: The ascent of mouse: advances in modelling human depression and anxiety , 2005, Nature Reviews Drug Discovery.

[357]  J. Vale,et al.  Trinucleotide Repeats in 202 Families With Ataxia , 2002 .

[358]  Ashley Harms Inflammation in Parkinson's disease. , 2001, Advances in neurology.

[359]  R. Yolken,et al.  Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder , 2000, Molecular Psychiatry.

[360]  H. Zoghbi,et al.  Trinucleotide repeats: mechanisms and pathophysiology. , 2000, Annual review of genomics and human genetics.

[361]  H. Zoghbi,et al.  Glutamine repeats and neurodegeneration. , 2000, Annual review of neuroscience.

[362]  Harding Ae Clinical features and classification of inherited ataxias. , 1993, Advances in neurology.

[363]  R. Lister Ethologically-based animal models of anxiety disorders. , 1990, Pharmacology & therapeutics.

[364]  B. Olivier,et al.  ETHOPHARMACOLOGY: A CREATIVE APPROACH TO IDENTIFICATION AND CHARACTERISATION OF NOVEL PSYCHOTROPICS , 1990, Drug metabolism and drug interactions.

[365]  S. Pellis,et al.  Different levels of complexity in the play-fighting by muroid rodents appear to result from different levels of intensity of attack and defense , 1989 .

[366]  J. Gray,et al.  The neuropsychology of anxiety. , 1985, Issues in mental health nursing.

[367]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[368]  R. Kataky,et al.  Citation for Published Item: Publisher's Copyright Statement: Use Policy , 2022 .

[369]  Shay Ohayon,et al.  Journal of Neuroscience Methods Automated Multi-day Tracking of Marked Mice for the Analysis of Social Behaviour , 2022 .